OXFORD — The New York Giants have given Ole Miss football quarterback Jaxson Dart a chance to break more of Eli Manning's records. The Giants selected Dart with the No. 25 pick in the first ...

On Friday, former Rebels and Giants QB Eli Manning officially welcomed Dart to the club. One day after hearing his name called in the first round, Dart made the trip up to the Giants facility ...

Eli Lilly is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so.Trading at $852 per share, LLY ...

Pharmaceutical giant Eli Lilly and Co. sued Willow Health Services and three other companies in federal court in New Jersey and California, accusing them of selling unapproved compounded ...

Will Jaxson Dart be the Giants’ next Eli Manning, after six mostly brutal seasons of Daniel Jones? Maybe. And if the second time is the charm for the Giants in their post-Manning years ...

Of course, that first one was Eli Manning in 2004, who went No. 1 to the Chargers before the Giants quickly swung a deal for him. Manning's history is well documented, including two Super Bowls.

At the March of the Living for Holocaust Remembrance Day, released hostage Eli Sharabi visited the March of the Living, spoke near the Auschwitz crematoria, and called for the release of all 59 ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs.

Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs. The ...

The weight loss drug market could grow to $500 billion over the next decade. Eli Lilly's next-generation products look promising, while competitors have stumbled in clinical trials. Investors are ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock stand now. The GLP-1 agonist opportunity is gearing up for its next ...

On Wednesday, pharmaceutical giant Eli Lilly sued four prominent telehealth companies that offer more affordable, off-brand versions of its patented best-selling GLP-1 medications Mounjaro and ...